Migraine headaches affect a significant portion of the population, with the Migraine Research Foundation reporting that about 25% of American households have someone suffering from migraines. Overall, around 12% of the U.S. population experiences this debilitating condition.

There’s good news for those dealing with refractory migraine pain: intravenous ketamine infusion treatment is emerging as an effective solution. At East Texas Ketamine Specialists, a clinic in Central Texas specializing in treatment-resistant depression, anxiety, and PTSD, we offer ketamine treatment specifically for refractory migraines, providing hope to those affected by this challenging condition.

East Texas Migraine Treatment

Migraines are not just severe headaches; they are complex neurological events that affect the entire nervous system and can cause a range of symptoms, including nausea, vomiting, vision problems, sensitivity to light, and vertigo. The intensity of these symptoms can be so debilitating that affected individuals may find themselves unable to carry out daily activities for several days.

The exact cause of migraines remains elusive to researchers. It is believed that various factors can trigger migraines, such as alcohol consumption, changes in weather and atmospheric pressure, stress, hormonal fluctuations, alterations in brain chemistry, and certain food additives.

Ketamine For Migraine Headaches

Intravenous ketamine, initially known for its use in anesthesia, has recently become a recognized treatment for refractory migraines. Over the past decade, its application has broadened to include other health issues. Ketamine shows remarkable effectiveness in managing certain chronic pain conditions and a range of treatment-resistant mental health and eating disorders, notably including depression. This expanded use highlights ketamine’s versatility and potential in various therapeutic areas beyond its traditional use.

The Science Behind Ketamine Treatment For Migraines Headaches

Ketamine, a dissociative anesthetic, primarily interacts with the brain’s N-methyl-D-aspartate (NMDA) receptors, along with opioid, monoaminergic, cholinergic, nicotinic, and muscarinic receptors. Its exact mechanism in treating refractory migraines is not fully understood. However, it’s believed that subanesthetic doses of ketamine can create a functional and electrophysiological separation between the thalamo-neocortical and limbic systems. This results in sensory inputs reaching the cortex without being fully processed in association areas. Essentially, ketamine may inhibit the neural pathways that contribute to migraine pain. A 2016 study in the Journal of Headache and Pain documented significant short-term improvement in patients with refractory chronic migraines following a single subanesthetic dose of intravenous ketamine.

Potential Contraindications

Although initial studies on ketamine for migraines are encouraging, ongoing research and caution are advised due to possible side effects. Patients might experience temporary effects such as drowsiness, speech difficulties, dizziness, nausea, vomiting, and agitation. Additionally, ketamine can raise heart rate and blood pressure, necessitating administration under the supervision of qualified medical professionals.

It’s essential for anyone considering ketamine treatment for refractory migraine headaches to consult with their healthcare provider. Discussing the potential benefits and risks with a medical professional ensures informed decision-making and safer treatment approaches.

Call Now Button